NB-BIOGLIM MF 1-500 SR

NB-Bioglim MF 1-500 SR combines Glimepiride (1 mg) and Metformin Hydrochloride (500 mg) in a sustained-release (SR) tablet form, commonly prescribed for the management of type 2 diabetes. Glimepiride is a sulfonylurea that helps lower blood sugar by stimulating insulin release from the pancreas. Metformin, a biguanide, works by improving insulin sensitivity and reducing glucose production in the liver. Together, these medications provide effective blood sugar control and help prevent complications related to diabetes, while the sustained-release formulation ensures long-lasting effects and a more convenient dosing schedule.